Altered bone development and an increase in FGF-23 expression in Enpp1 -/- mice

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Mackenzie, Neil Charles Wallace ^a   Zhu, Dongxing ^a   Milne, Elspeth M ^a   van't Hof, Rob ^b   Martin, Aline ^d   Quarles, Darryl Leigh ^d   Millán, José Luis ^c   Farquharson, Colin ^a   MacRae, Vicky Elisabeth ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; NUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; OSTEOCALCIN; PHOSPHATE; PHOSPHODIESTERASE I; UNCLASSIFIED DRUG; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; FIBROBLAST GROWTH FACTOR; INORGANIC PYROPHOSPHATASE; PHOSPHODIESTERASE;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE DEVELOPMENT; BONE MASS; BONE MATURATION; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CALCIFICATION; CELL COUNT; CONTROLLED STUDY; FEMALE; GROWTH RATE; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCLAST; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; METABOLISM; MOUSE MUTANT; OSTEOBLAST; PHYSIOLOGY;

ANIMALS; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; CALCIUM; FIBROBLAST GROWTH FACTORS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; PHOSPHATES; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RNA, MESSENGER;

EID: 84857130445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032177     Document Type: Article

References (62)

1. Lakkakorpi PT, Vaananen HK, (1996) Cytoskeletal changes in osteoclasts during the resorption cycle. Microscopy Research and Technique 33: 171-181.
2. Mulari MTK, Zhao H, Lakkakorpi PT, Vaananen HK, (2003) Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4: 113-125.
3. Anderson HC, (2003) Matrix vesicles and calcification. Current rheumatology reports 5: 222-226.
4. Anderson HC, Stechschulte DJ, Collins DE, Jacobs DH, Morris DC, et al. (1990) Matrix vesicle biogenesis in vitro by rachitic and normal rat chondrocytes. American Journal of Pathology 136: 391-398.
5. Cecil RNA, Anderson HC, (1978) Freeze-fracture studies of matrix vesicle calcification in epiphyseal growth plate. Metabolic Bone Disease & Related Research 1: 89-95.
6. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, et al. (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 279: R1365-R1377.
7. Johnson K, Goding J, Van Etten D, Sali A, Hu SI, et al. (2003) Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. Journal of Bone and Mineral Research 18: 994-1004.
8. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, et al. (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proceedings of the National Academy of Sciences of the United States of America 99: 9445-9449.
9. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, et al. (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank- An integrated model of the pathogenesis of mineralization disorders. American Journal of Pathology 164: 1199-1209.
10. Harmey D, Johnson KA, Zelken J, Camacho NP, Hoylaerts MF, et al. (2006) Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. Journal of Bone and Mineral Research 21: 1377-1386.
11. Liu S, Zhou J, Tang W, Menard R, Feng JQ, et al. (2008) Pathogenic role of Fgf23 in Dmp1-null mice. American Journal of Physiology-Endocrinology and Metabolism 295: E254-E261.
12. Meyer JL, (1984) Can biological calcification occur in the presence of pyrophosphate. Archives of Biochemistry and Biophysics 231: 1-8.
13. Sodek J, Ganss B, McKee MD, (2000) Osteopontin. Critical Reviews in Oral Biology & Medicine 11: 279-303.
14. Murshed M, Schinke T, McKee MD, Karsenty G, (2004) Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. Journal of Cell Biology 165: 625-630.
15. Liu SG, Zhou JP, Tang W, Jiang X, Rowe DW, et al. (2006) Pathogenic role of Fgf23 in Hyp mice. American Journal of Physiology-Endocrinology and Metabolism 291: E38-E49.
16. Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, et al. (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86: 273-278.
17. Lorenz-Depiereux B, Schnabel D, Tiosano D, Haeusler G, Strom TM, (2010) Loss-of-Function ENPP1 Mutations Cause Both Generalized Arterial Calcification of Infancy and Autosomal-Recessive Hypophosphatemic Rickets. American Journal of Human Genetics 86: 267-272.
18. Chen IP, Wang L, Jiang X, Aguila HL, Reichenberger EJ, (2011) A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD). Hum Mol Genet 20: 948-961.
19. Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD, (2007) Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. Journal of Biological Chemistry 282: 15872-15883.
20. Terkeltaub R, Rosenbach M, Fong F, Goding J, (1994) Casual link between nucleotide pyrophosphohydolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma-cell membrane glycoprotein-1- Relevance to calcium pyrophosphate dihydrate deposition disease. Arthritis and Rheumatism 37: 934-941.
21. Ho AM, Johnson MD, Kingsley DM, (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289: 265-270.
22. Hakim FT, Cranley R, Brown KS, Eanes ED, Harne L, et al. (1984) Hereditary joint disorder in progressive ankylosis (ANK ANK) mice. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis and Rheumatism 27: 1411-1420.
23. Moss DW, Eaton RH, Smith JK, Whitby LG, (1966) Association of pyrophosphatase activity with human alkaline phosphatase preparations. Biochemical Journal 102: 53-57.
24. Majeska RJ, Wuthier RE, (1975) Studies on matrix vesicles isolated from chick epiphyseal cartilage- association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochimica Et Biophysica Acta 391: 51-60.
25. Hessle L, Johnson KA, Anderson HC, Terkeltaub R, Millan JL, (2002) TNAP and PC-1 control bone mineral deposition by directly regulating pyrophosphate levels. Journal of Bone and Mineral Research 17: S128-S128.
26. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G, (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes & Development 19: 1093-1104.
27. Sali A, Favaloro J, Terkeltaub R, Goding J, (1999) Germline deletion of the nucleoside triphosphate pyrophosphohydrolase (NTPPPH) plasma cell membrane glycoprotein-1 (PC-1) produces abnormal calcification of periarticular tissues. In: Vanduffel L, Lemmems R, editors. Ecto-ATPases and Related Ectoenzymes: Shaker Publishing pp. 267-282.
28. Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, et al. (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleoticle pyrophosphatase phosphodiesterase 1 double-deficient mice. American Journal of Pathology 166: 1711-1720.
29. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, et al. (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. Journal of the American Society of Nephrology 15: 2857-2867.
30. Demer LL, Tintut Y, (2008) Vascular calcification- Pathobiology of a multifaceted disease. Circulation 117: 2938-2948.
31. Johnson K, Terkeltaub R, (2005) Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage. Frontiers in Bioscience 10: 988-997.
32. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, et al. (2001) PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. American Journal of Pathology 158: 543-554.
33. Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, et al. (2003) Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nature Genetics 34: 379-381.
34. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, et al. (1998) Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nature Genetics 19: 271-273.
35. Baba H, Furusawa N, Fukuda M, Maezawa Y, Imura S, et al. (1997) Potential role of streptozotocin in enhancing ossification of the posterior longitudinal ligament of the cervical spine in the hereditary spinal hyperostotic mouse (twy/twy). European Journal of Histochemistry 41: 191-202.
36. Furusawa N, Baba H, Imura S, Fukuda M, (1996) Characteristics and mechanism of the ossification of posterior longitudinal ligament in the tip-toe walking Yoshimura (twy) mouse. European Journal of Histochemistry 40: 199-210.
37. Okawa A, Goto S, Moriya H, (1999) Calcitonin simultaneously regulates both periosteal hyperostosis and trabecular osteopenia in the spinal hyperostotic mouse (twy/twy) in vivo. Calcified Tissue International 64: 239-247.
38. Sakamoto M, Hosoda Y, Kojimahara K, Yamazaki T, Yoshimura Y, (1994) Arthritis and ankylosis in TWY mice with hereditary multiple osteochondral lesions- with special reference to calcium dopesition. Pathology International 44: 420-427.
39. Chen IP, Wang L, Jiang X, Aguila HL, Reichenberger EJ, (2011) A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD). Human Molecular Genetics 20: 948-961.
40. Owen HC, Ahmed SF, Farquharson C, (2009) Chondrocyte p21(WAF1/CIP1) Expression Is Increased by Dexamethasone but Does Not Contribute to Dexamethasone-Induced Growth Retardation In Vivo. Calcified Tissue International 85: 326-334.
41. Huesa C, Yadav MC, Finnila MAJ, Goodyear SR, Robins SP, et al. (2011) PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone 48: 1066-1074.
42. Hildebrand T, Ruegsegger P, (1997) A new method for the model-independent assessment of thickness in three-dimensional images. Journal of Microscopy 185: 67-75.
43. Petersen CB, Nygard AB, Viuff B, Fredholm M, Aasted B, et al. (2007) Porcine ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1/CD203a): Cloning, transcription, expression, mapping, and identification of an NPP1/CD203a epitope for swine workshop cluster 9 (SWC9) monoclonal antibodies. Developmental and Comparative Immunology 31: 618-631.
44. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP, (1992) Different missense mutations at the tissue-nonspecific alkaline-phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proceedings of the National Academy of Sciences of the United States of America 89: 9924-9928.
45. Johnson K, Pritzker K, Goding J, Terkeltaub R, (2001) The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. Journal of Rheumatology 28: 2681-2691.
46. Johnson K, Polewski M, van Etten D, Terkeltaub R, (2005) Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice. Arteriosclerosis Thrombosis and Vascular Biology 25: 686-691.
47. Babij P, Roudier M, Graves T, Han C-YE, Chhoa M, et al. (2009) New Variants in the Enpp1 and Ptpn6 Genes Cause Low BMD, Crystal-Related Arthropathy, and Vascular Calcification. Journal of Bone and Mineral Research 24: 1552-1564.
48. Nam HK, Liu J, Li Y, Kragor A, Hatch NE, (2011) Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation. The Journal of biological chemistry 286: 39059-39071.
49. Prosdocimo DA, Douglas DC, Romani AM, O'Neill WC, Dubyak GR, (2009) Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. American Journal of Physiology-Cell Physiology 296: C828-C839.
50. Orriss IR, Burnstock G, Arnett TR, (2010) Purinergic signalling and bone remodelling. Current Opinion in Pharmacology 10: 322-330.
51. Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, et al. (2006) Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Nature Clinical Practice Endocrinology & Metabolism 2: 694-701.
52. Dong HJ, Maddux BA, Altomonte J, Meseck M, Accili D, et al. (2005) Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes 54: 367-372.
53. Chambers TJ, Magnus CJ, (1982) Calcitonin alters behaviour of isolated osteoclass. Journal of Pathology 136: 27-39.
54. Ferron M, Hinoi E, Karsenty G, Ducy P, (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America 105: 5266-5270.
55. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, et al. (2010) Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism. Cell 142: 296-308.
56. Chang EJ, Ha J, Oerlemans F, Lee YJ, Lee SW, et al. (2008) Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nature Medicine 14: 966-972.
57. Sekrecka-Belniak A, Balcerzak M, Buchet R, Pikula S, (2010) Active creatine kinase is present in matrix vesicles isolated from femurs of chicken embryo: Implications for bone mineralization. Biochemical and Biophysical Research Communications 391: 1432-1436.
58. Quarles LD, (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828.
59. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, et al. (2007) The parathyroid is a target organ for FGF23 in rats. Journal of Clinical Investigation 117: 4003-4008.
60. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, et al. (2006) Regulation of fibroblast growth factor-23 signaling by Klotho. Journal of Biological Chemistry 281: 6120-6123.
61. Martin A, Liu S, David V, Li H, Karydis A, et al. (2011) Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. Faseb Journal 25: 2551-2562.
62. Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, et al. (2008) Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone. Plos Genetics 4: 10.